BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30093623)

  • 1. Short and Long-Term Potential Role of Carbon Nanoparticles in Total Thyroidectomy with Central Lymph Node Dissection.
    Xue S; Ren P; Wang P; Chen G
    Sci Rep; 2018 Aug; 8(1):11936. PubMed ID: 30093623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of carbon nanoparticles accelerates the rapid recovery of parathyroid function during thyroid carcinoma surgery with central lymph node dissection: A retrospective cohort study.
    Wang B; Du ZP; Qiu NC; Liu ME; Liu S; Jiang DZ; Zhang W; Qiu M
    Int J Surg; 2016 Dec; 36(Pt A):164-169. PubMed ID: 27989915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reoperative central lymph node dissection for incidental papillary thyroid cancer can be performed safely: A retrospective review.
    Hall CM; LaSeur DC; Snyder SK; Lairmore TC
    Int J Surg; 2018 Aug; 56():102-107. PubMed ID: 29920338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbon nanoparticles facilitate lymph nodes dissection and parathyroid glands identification in reoperation of papillary thyroid cancer.
    Su AP; Wang B; Gong YP; Wu WS; Gong RX; Li ZH; Zhu JQ
    Medicine (Baltimore); 2017 Nov; 96(44):e8380. PubMed ID: 29095266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central lymph node dissection as a secondary procedure for papillary thyroid cancer: Is there added morbidity?
    Alvarado R; Sywak MS; Delbridge L; Sidhu SB
    Surgery; 2009 May; 145(5):514-8. PubMed ID: 19375610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic central lymph node dissection for clinically node-negative papillary thyroid microcarcinoma: influence on serum thyroglobulin level, recurrence rate, and postoperative complications.
    So YK; Seo MY; Son YI
    Surgery; 2012 Feb; 151(2):192-8. PubMed ID: 21497873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central lymph node dissection and permanent hypoparathyroidism after total thyroidectomy for papillary thyroid cancer: population-based study.
    Salem FA; Bergenfelz A; Nordenström E; Almquist M
    Br J Surg; 2021 Jun; 108(6):684-690. PubMed ID: 34157088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of hypoparathyroidism after central compartment lymph node dissection in the surgical treatment of pT1, N0 thyroid papillary carcinoma.
    Aydin OU; Soylu L; Ozbas S; Ilgan S; Bilezikci B; Gursoy A; Sengezer T; Kocak S
    Eur Rev Med Pharmacol Sci; 2016 May; 20(9):1781-7. PubMed ID: 27212170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine central lymph node dissection with total thyroidectomy for papillary thyroid cancer potentially minimizes level VI recurrence.
    Hall CM; Snyder SK; Maldonado YM; Lairmore TC
    Surgery; 2016 Oct; 160(4):1049-1058. PubMed ID: 27521047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbon Nanoparticles for Thyroidectomy and Central Lymph Node Dissection for Thyroid Cancer.
    Zhang RJ; Chen YL; Deng X; Yang H
    Am Surg; 2023 Jun; 89(6):2227-2236. PubMed ID: 35387525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autotransplantation of Inferior Parathyroid glands during central neck dissection for papillary thyroid carcinoma: a retrospective cohort study.
    Wei T; Li Z; Jin J; Chen R; Gong Y; Du Z; Gong R; Zhu J
    Int J Surg; 2014 Dec; 12(12):1286-90. PubMed ID: 25448646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of carbon nanoparticles in patients with thyroid carcinoma undergoing total thyroidectomy plus bilateral central neck dissection].
    Wu G; Cai L; Hu J; Zhao R; Ge J; Zhao Y; Shi J; Wang Z
    Zhonghua Yi Xue Za Zhi; 2015 Mar; 95(12):912-6. PubMed ID: 26081053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Level VI lymph node dissection for papillary thyroid cancer.
    White ML; Doherty GM
    Minerva Chir; 2007 Oct; 62(5):383-93. PubMed ID: 17947949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbon nanoparticle-guided central lymph node dissection in clinically node-negative patients with papillary thyroid carcinoma.
    Zhu Y; Chen X; Zhang H; Chen L; Zhou S; Wu K; Wang Z; Kong L; Zhuang H
    Head Neck; 2016 Jun; 38(6):840-5. PubMed ID: 25832013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Carbon Nanoparticle Lymphatic Tracer Protected Parathyroid Glands During Radical Thyroidectomy for Papillary Thyroid Non-Microcarcinoma.
    Long M; Luo D; Diao F; Huang M; Huang K; Peng X; Lin S; Li H
    Surg Innov; 2017 Feb; 24(1):29-34. PubMed ID: 27634477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single inferior parathyroid autotransplantation during total thyroidectomy with bilateral central lymph node dissection for papillary thyroid carcinoma: a retrospective cohort study.
    Dong Z; Liu W; Peng Y; Zhan X; Su Y; Diao C; Cheng R
    World J Surg Oncol; 2023 Mar; 21(1):102. PubMed ID: 36959661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extent of prophylactic lymph node dissection in the central neck area of the patients with papillary thyroid carcinoma: comparison of limited versus comprehensive lymph node dissection in a 2-year safety study.
    Son YI; Jeong HS; Baek CH; Chung MK; Ryu J; Chung JH; So YK; Jang JY; Choi J
    Ann Surg Oncol; 2008 Jul; 15(7):2020-6. PubMed ID: 18459004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of carbon nano-particles in total thyroidectomy combined with lymphadenectomy in area Ⅵ].
    Qian YC; Liu FZ; Yao WP; Zhao YB; Jiang Y; Zhang Y
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jan; 54(1):28-32. PubMed ID: 30704166
    [No Abstract]   [Full Text] [Related]  

  • 19. Routine bilateral central lymph node clearance for papillary thyroid cancer.
    Sadowski BM; Snyder SK; Lairmore TC
    Surgery; 2009 Oct; 146(4):696-703; discussion 703-5. PubMed ID: 19789029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical application of carbon nanoparticles suspension in operation of papillary thyroid carcinoma].
    Wang C; Wang X; Liu L
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Feb; 34(2):165-169. PubMed ID: 32086925
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.